Tremblay Elise, Laffel Lori
Division of Endocrinology, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
J Diabetes Sci Technol. 2025 Jun 9:19322968251345836. doi: 10.1177/19322968251345836.
Despite rapidly evolving diabetes technology and evidence that early access to technologies improves outcomes, there is disparate use based on socio-demographic factors. We sought to characterize technology uptake in the year following diagnosis of type 1 diabetes in youth based on race/ethnicity, insurance, and household structure.
We conducted a retrospective cohort study of 692 youth diagnosed with and treated for type 1 diabetes between 2016 and 2020 at a children's hospital. Medical record review provided outcomes of interest, including time to initiation of continuous glucose monitors (CGMs), insulin pump therapy, or both. We used cumulative incidence curves and competing risks regression to compare time to initiation by socio-demographic groups.
There were 692 youth, 59% male, diagnosed at a mean age of 10.8 (±4.2) years, in the sample. The majority (83.2%) were White, English-speaking (94.4%), and privately insured (76.7%), with 71.7% living in two-parent households. Cumulative incidence curves and competing risks regression showed that publicly insured youth had a lower likelihood of starting diabetes technologies in the year following diagnosis than privately insured youth. Black and Hispanic youth were less likely than white youth to start CGM and insulin pumps. Youth from non-intact households similarly exhibited lower rates of technology uptake. Hazard ratios for time to both technologies were comparable to those for time to insulin pump.
These findings highlight the importance of developing interventions to advance diabetes technology use from onset of type 1 diabetes for all youth.
尽管糖尿病技术发展迅速,且有证据表明早期使用这些技术可改善治疗效果,但基于社会人口统计学因素的使用情况存在差异。我们试图根据种族/族裔、保险和家庭结构,描述青少年1型糖尿病确诊后一年内技术的采用情况。
我们对2016年至2020年期间在一家儿童医院被诊断并接受治疗的692名青少年1型糖尿病患者进行了一项回顾性队列研究。病历审查提供了感兴趣的结果,包括开始使用持续葡萄糖监测仪(CGM)、胰岛素泵治疗或两者的时间。我们使用累积发病率曲线和竞争风险回归来比较不同社会人口统计学组开始使用的时间。
样本中有692名青少年,其中59%为男性,平均诊断年龄为10.8(±4.2)岁。大多数(83.2%)是白人,说英语(94.4%),有私人保险(76.7%),71.7%生活在双亲家庭。累积发病率曲线和竞争风险回归显示,与有私人保险的青少年相比,公共保险的青少年在确诊后一年内开始使用糖尿病技术的可能性较低。黑人和西班牙裔青少年开始使用CGM和胰岛素泵的可能性低于白人青少年。来自不完整家庭的青少年同样表现出较低的技术采用率。两种技术开始使用时间的风险比与胰岛素泵开始使用时间的风险比相当。
这些发现凸显了制定干预措施以促进所有青少年从1型糖尿病发病起就使用糖尿病技术的重要性。